Cargando…
Commentary: Polygenic risk for breast cancer: in search for potential clinical utility
Autores principales: | Wang, Tingting, Ala-Korpela, Mika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295014/ https://www.ncbi.nlm.nih.gov/pubmed/34999886 http://dx.doi.org/10.1093/ije/dyab230 |
Ejemplares similares
-
Implementation and utilization of hypofractionation for breast cancer
por: Gilbo, Philip, et al.
Publicado: (2018) -
Nationwide Trends in Heart-Sparing Techniques Utilized in Radiation Therapy for Breast Cancer
por: Desai, Nina, et al.
Publicado: (2019) -
Diabetes risk reduction diet and the risk of breast cancer
por: Turati, Federica, et al.
Publicado: (2021) -
Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin‐Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations
por: Spring, Laura M., et al.
Publicado: (2017) -
Long-term weight change and risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) study
por: Ellingjord-Dale, Merete, et al.
Publicado: (2021)